Created at	Source	Raw Value	Validated value
July 17, 2022, 3:30 a.m.	usa	To evaluate the effectiveness of molnupiravir compared to placebo in preventing severe disease progression in adults with mild COVID-19;To evaluate the safety of molnupiravir in adults with mild COVID-19;To evaluate the safety of molnupiravir in adults with mild COVID-19	To evaluate the effectiveness of molnupiravir compared to placebo in preventing severe disease progression in adults with mild COVID-19;To evaluate the safety of molnupiravir in adults with mild COVID-19;To evaluate the safety of molnupiravir in adults with mild COVID-19